Association Between Hepatitis C Infection and Renal Cell Carcinoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characterization of Clonal B Cell Populations in HCV Infection

NCT00435201

Hepatitis C

COMPLETED

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

NCT00004850

Hepatitis C Hepatitis B

COMPLETED

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

NCT02366286

Hepatitis B Hepatitis C Carcinoma, Hepatocellular

COMPLETED

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

NCT00342641

Hepatitis C Virus

COMPLETED

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

NCT01350648

Hepatitis B Hepatitis C HIV-HCV Co-Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis C Renal Cell Carcinoma Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Renal Cell Carcinoma patients

Newly diagnosed (within 6 months) renal cell carcinoma patients in who a biopsy or surgery will be performed

Hepatitis C testing

Intervention Type OTHER

Hepatitis C antibody, Hepatitis C RNA quantitative and for those who test positive Hepatitis C genotype

Colorectal cancer patients

Newly diagnosed (6 months) colon cancer patients

Hepatitis C testing

Intervention Type OTHER

Hepatitis C antibody, Hepatitis C RNA quantitative and for those who test positive Hepatitis C genotype

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hepatitis C testing

Hepatitis C antibody, Hepatitis C RNA quantitative and for those who test positive Hepatitis C genotype

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months.
* Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months

Exclusion Criteria

* Patients who are unwilling to provide consent
* Patients who decline to complete a questionnaire
* Patient in who blood sample cannot be obtained
* Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No